NEW YORK, May 22, 2023 /PRNewswire/ Seelos Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare. | May 22, 2023
/PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for.
NORTH PROVIDENCE – Ronnie Giorgio says he firmly believes if his horrific car crash hadn’t happened where it did, near Rhode Island Hospital, he likely wouldn’t be on the comeback
- The Expanded Access Program is funded by a grant from the National Institute of Neurological Disorders and Stroke under the Accelerating Access to Critical Therapies for ALS for ALS patients who. | April 4, 2023
NEW YORK, March 29, 2023 /PRNewswire/ Seelos Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare. | March 29, 2023